Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
367
datasets available to search
ShareScore release 0.9.0
Dataset results
367 results for “Ibrutinib”
A Study to Evaluate the Effect of Ibrutinib on the Pharmacokinetics of Oral Contraceptives, CYP2B6, and CYP3A4 Substrates in Female Participants With B Cell Malignancy
ClinicalTrials.gov study NCT03301207. IPD Sharing: Not stated. Countries: 2. Publications: 1.
A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults
ClinicalTrials.gov study NCT02638116. IPD Sharing: Not stated. Countries: 1. Publications: 1.
IBER Salvage Treatment Followed by Ibrutinib Maintenance for Relapsed or Refractory PCNSL
ClinicalTrials.gov study NCT04066920. IPD Sharing: Not stated. Countries: 1. Publications: 16.
LOC-R01 Study of Lenalidomide and Ibrutinib in Association With Rituximab-Methotrexate Procarbazine Vincristin (R-MPV)
ClinicalTrials.gov study NCT04446962. IPD Sharing: YES. Countries: 1. Publications: 1.
Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies
ClinicalTrials.gov study NCT02006485. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bruton's Tyrosine Kinase (BTK) Inhibitor, Ibrutinib, in Patients With Newly Diagnosed or Refractory/Recurrent Primary Central Nervous System Lymphoma (PCNSL) and Refractory/Recurrent Secondary Central
ClinicalTrials.gov study NCT02315326. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Ibrutinib, Bortezomib and Rituximab-CHOP for the Treatment of Elderly Patients With CD20+ DLBCL, IPI ≥ 2
ClinicalTrials.gov study NCT03129828. IPD Sharing: NO. Countries: 1. Publications: 2.
Chronic Ibrutinib Therapy Effect on Left Atrial Function
ClinicalTrials.gov study NCT03751410. IPD Sharing: NO. Countries: 1. Publications: 11.
Phase II Palbociclib +Ibrutinib in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03478514. IPD Sharing: UNDECIDED. Countries: 1. Publications: 8.
Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT03755947. IPD Sharing: Not stated. Countries: 1. Publications: 12.
Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL
ClinicalTrials.gov study NCT02758665. IPD Sharing: YES. Countries: 1. Publications: 1.
Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients with Previou
ClinicalTrials.gov study NCT02950051. IPD Sharing: NO. Countries: 10. Publications: 5.
ABT-199 & Ibrutinib in Mantle Cell Lymphoma (AIM)
ClinicalTrials.gov study NCT02471391. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Ibrutinib and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02219737. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ibrutinib and Palbociclib in Treating Patients With Previously Treated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02159755. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Venetoclax and Ibrutinib in Treating Patients With Chronic or Small Lymphocytic Leukemia
ClinicalTrials.gov study NCT02756897. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Sequential Regimen of Bendamustin-Debulking Followed by Ofatumumab and Ibrutinib in CLL Patients (CLL2-BIO)
ClinicalTrials.gov study NCT02689141. IPD Sharing: NO. Countries: 1. Publications: 3.
Ibrutinib and Acalabrutinib Use and Risk of Atrial Fibrillation in Patients With Chronic B-cell Malignancies
ClinicalTrials.gov study NCT06561243. IPD Sharing: NO. Countries: 1. Publications: 1.
Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL
ClinicalTrials.gov study NCT03708003. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL
ClinicalTrials.gov study NCT02747732. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.